Table 3

Factors associated with RFS in 49 patients with mastocytosis treated by 2-CdA

CovariatesHR95% CIP
Male gender 0.69 0.34-1.42 .31 
AHNMD vs ISM/SSM/CM/MIS 0.66 0.25-1.73 .40 
ASM vs ISM/SSM/CM/MIS 1.20 0.46-3.18 .71 
Age at mastocytosis diagnosis >50 y 1.25 0.62-2.52 .53 
Age at 2-CdA initiation >55 y 0.73 0.36-1.49 .39 
Fatigue 0.84 0.38-1.86 .66 
Flush 1.22 0.61-2.46 .58 
Pruritus 1.61 0.79-3.29 .19 
Abdominal pain 1.82 0.91-3.63 .09 
Diarrhea 1.39 0.69-2.81 .36 
Hepatosplenomegaly 1.06 0.53-2.09 .88 
Urticaria pigmentosa 1.42 0.70-0.55 .46 
Bone involvement (yes vs no) 0.50 0.24-1.04 .06 
Anemia <10g/dL 1.18 0.49-2.88 .71 
>3 courses of 2-CdA 1.72 0.84-3.49 .14 
>4 courses of 2-CdA 2.79 1.30-6.02 .009 
Partial response 2.16 1.05-4.44 .037 
CovariatesHR95% CIP
Male gender 0.69 0.34-1.42 .31 
AHNMD vs ISM/SSM/CM/MIS 0.66 0.25-1.73 .40 
ASM vs ISM/SSM/CM/MIS 1.20 0.46-3.18 .71 
Age at mastocytosis diagnosis >50 y 1.25 0.62-2.52 .53 
Age at 2-CdA initiation >55 y 0.73 0.36-1.49 .39 
Fatigue 0.84 0.38-1.86 .66 
Flush 1.22 0.61-2.46 .58 
Pruritus 1.61 0.79-3.29 .19 
Abdominal pain 1.82 0.91-3.63 .09 
Diarrhea 1.39 0.69-2.81 .36 
Hepatosplenomegaly 1.06 0.53-2.09 .88 
Urticaria pigmentosa 1.42 0.70-0.55 .46 
Bone involvement (yes vs no) 0.50 0.24-1.04 .06 
Anemia <10g/dL 1.18 0.49-2.88 .71 
>3 courses of 2-CdA 1.72 0.84-3.49 .14 
>4 courses of 2-CdA 2.79 1.30-6.02 .009 
Partial response 2.16 1.05-4.44 .037 

AHNMD, associated hematologic non–mast cell disease; ASM, aggressive systemic mastocytosis; CM, cutaneous mastocytosis; ISM, indolent systemic mastocytosis; MIS, mastocytosis in the skin; SSM, smoldering systemic mastocytosis

Bold indicates significant parameters in univariate analysis.

Close Modal

or Create an Account

Close Modal
Close Modal